Teoh G, Urashima M, Greenfield E A, Nguyen K A, Lee J F, Chauhan D, Ogata A, Treon S P, Anderson K C
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Clin Invest. 1998 Mar 15;101(6):1379-88.
Previous studies have shown that triggering multiple myeloma (MM) cells via CD40 induces IL-6-mediated autocrine growth as well as increased expression of cell surface adhesion molecules including CD11a, CD11b, CD11c, and CD18. In this study, we generated the 5E2 mAb which targets an antigen that is induced upon CD40 ligand (CD40L) activation of MM cells. Immunofluorescence, immunoprecipitation, and protein sequencing studies identified the target antigen of 5E2 mAb as the 86-kD subunit of the Ku autoantigen. We demonstrate that increased cell surface expression of Ku on CD40L-treated cells is due to migration of Ku from the cytoplasm to the cell surface membrane. Moreover, cell surface Ku on CD40L-treated MM cells mediates homotypic adhesion of tumor cells, as well as heterotypic adhesion of tumor cells to bone marrow stromal cells and to human fibronectin; and 5E2 mAb abrogates IL-6 secretion triggered by tumor cell adherence to bone marrow stromal cells. These data suggest that CD40L treatment induces a shift of Ku from the cytoplasm to the cell surface, and are the first to show that Ku functions as an adhesion molecule. They further suggest that cell surface Ku may play a role in both autocrine and paracrine IL-6-mediated MM cell growth and survival.
先前的研究表明,通过CD40激活多发性骨髓瘤(MM)细胞可诱导IL-6介导的自分泌生长,以及包括CD11a、CD11b、CD11c和CD18在内的细胞表面粘附分子表达增加。在本研究中,我们制备了5E2单克隆抗体,其靶向一种在MM细胞被CD40配体(CD40L)激活时诱导产生的抗原。免疫荧光、免疫沉淀和蛋白质测序研究确定5E2单克隆抗体的靶抗原为Ku自身抗原的86-kD亚基。我们证明,CD40L处理的细胞上Ku的细胞表面表达增加是由于Ku从细胞质迁移到细胞表面膜。此外,CD40L处理的MM细胞上的细胞表面Ku介导肿瘤细胞的同型粘附,以及肿瘤细胞与骨髓基质细胞和人纤连蛋白的异型粘附;并且5E2单克隆抗体可消除肿瘤细胞粘附于骨髓基质细胞触发的IL-6分泌。这些数据表明,CD40L处理诱导Ku从细胞质转移到细胞表面,并且首次表明Ku作为一种粘附分子发挥作用。它们进一步表明,细胞表面Ku可能在自分泌和旁分泌IL-6介导的MM细胞生长和存活中发挥作用。